These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 17186017)
1. Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Jordan VC Nat Rev Cancer; 2007 Jan; 7(1):46-53. PubMed ID: 17186017 [TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of breast cancer. O'Regan RM; Jordan VC Cancer Treat Res; 2001; 106():137-54. PubMed ID: 11225001 [No Abstract] [Full Text] [Related]
3. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Park WC; Jordan VC Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274 [TBL] [Abstract][Full Text] [Related]
4. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. Jordan VC; Gapstur S; Morrow M J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060 [TBL] [Abstract][Full Text] [Related]
6. Progress in the prevention of breast cancer: concept to reality. Jordan VC J Steroid Biochem Mol Biol; 2000 Nov; 74(5):269-77. PubMed ID: 11162935 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer chemoprevention: a review of selective estrogen receptor modulators. Johansen AM Clin J Oncol Nurs; 2005 Jun; 9(3):317-20. PubMed ID: 15973842 [TBL] [Abstract][Full Text] [Related]
9. The endometrial effects of SERMs. Cano A; Hermenegildo C Hum Reprod Update; 2000; 6(3):244-54. PubMed ID: 10874569 [TBL] [Abstract][Full Text] [Related]
10. Beyond raloxifene for the prevention of osteoporosis and breast cancer. Jordan VC Br J Pharmacol; 2007 Jan; 150(1):3-4. PubMed ID: 17115068 [TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast. Pickar JH; Komm BS Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836 [TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of breast cancer. Dalton RR; Kallab AM South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947 [TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ. Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD Breast J; 2015; 21(4):377-86. PubMed ID: 25879521 [TBL] [Abstract][Full Text] [Related]
14. The selective estrogen receptor modulators in breast cancer prevention. Li F; Dou J; Wei L; Li S; Liu J Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504 [TBL] [Abstract][Full Text] [Related]
15. The search for the ideal SERM. Arun B; Anthony M; Dunn B Expert Opin Pharmacother; 2002 Jun; 3(6):681-91. PubMed ID: 12036407 [TBL] [Abstract][Full Text] [Related]
16. A pharmacological review of selective oestrogen receptor modulators. Goldstein SR; Siddhanti S; Ciaccia AV; Plouffe L Hum Reprod Update; 2000; 6(3):212-24. PubMed ID: 10874566 [TBL] [Abstract][Full Text] [Related]
17. Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade. Gajdos C; Jordan VC Clin Breast Cancer; 2002 Jan; 2(4):272-81. PubMed ID: 11899358 [TBL] [Abstract][Full Text] [Related]
18. Modulation of the oestrogen receptor: a process with distinct susceptible steps. Cano A; Hermenegildo C Hum Reprod Update; 2000; 6(3):207-11. PubMed ID: 10874565 [TBL] [Abstract][Full Text] [Related]
19. Novel agents to modulate oestrogen action. Dardes RC; Jordan VC Br Med Bull; 2000; 56(3):773-86. PubMed ID: 11255561 [TBL] [Abstract][Full Text] [Related]